Many of the most significant healthcare fraud cases involve services that were actually provided — and claims that were legitimately submitted. The fraud is in what influenced the decision to provide them, and whether the government would have paid if it had known the full picture.
Healthcare fraud under the False Claims Act is the largest and most actively enforced category — accounting for more than 83% of FY2025 recoveries. But the most significant cases are rarely about fabricated procedures or phantom patients.
Many of the most important cases involve services that were provided, claims that were submitted, but decisions that were influenced by improper factors — financial relationships, kickbacks, or incentives that corrupted the clinical judgment behind the care.
The legal question the government asks is not "did this procedure happen?" It is: "Did the government pay for care based on information or decisions that complied with the rules governing the program?" That distinction — between care that occurred and care that was lawfully reimbursable — is where most healthcare FCA cases live.
An Oregon-based medical device manufacturer resolved allegations that it provided excessive training payments, travel, and entertainment to physicians to influence their choice of devices — with claims then submitted to Medicare and Medicaid.
Received by the whistleblowers who brought the case forward.
Federal law prohibits paying anything of value to influence medical decision-making. When physicians select devices, prescribe medications, or refer patients based on financial incentives rather than clinical judgment, any resulting claims to Medicare or Medicaid may be considered legally false — not because the care didn't happen, but because the government would not have paid had it known the real basis for the decision. This is one of the most important and frequently misunderstood principles in healthcare FCA enforcement.
Healthcare FCA cases require careful threshold analysis before filing. The evaluation focuses on four core questions — and the evidence that answers them.
The specific certifications, billing codes, and eligibility representations that triggered government payment — and whether they were accurate.
Whether financial relationships, payments, or inducements affected the clinical or business decisions behind the claims.
Compliance flags, internal objections, or audit findings that were overridden or suppressed are among the most powerful evidence in healthcare FCA cases.
Systematic conduct across multiple providers, payers, or time periods is stronger than a single billing error, and determines both the scale of damages and DOJ's interest.